- Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
-
Kim HW, Kim JL, Lee MH, Yoo HG, Chung IY, Lee JE
- KMID: 1018409
- Korean J Ophthalmol.
- 2011 Aug;25(4):231-237.
- doi: 10.3341/kjo.2011.25.4.231
PURPOSE: To evaluate the outcome of a combined photodynamic therapy and intravitreal injection of bevacizumab in choroidal neovascularization secondary to age-related macular degeneration. METHODS: Photodynamic therapy (PDT) was administered to 28... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
-
Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2373986
- Korean J Ophthalmol.
- 2016 Aug;30(4):265-271.
- doi: 10.3341/kjo.2016.30.4.265
PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent... -
- CITED
-
- Close
- SHARE
-
- Close
